Applied UV Announces Global Technology Thought Leader John F. Andrews Joins As Chief Executive Officer and Director
April 08 2022 - 8:00AM
Business Wire
Applied UV, Inc. (NasdaqCM: AUVI) (“Applied UV” or the
“Company”), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light (“UVC”) for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announces that John F. Andrews has joined the Company serving as
Chief Executive Officer and a member of the Board of Directors.
John F. Andrews has over 30 years of senior leadership
experience in telecom and technology companies, both public and
private. He has been CEO of several public companies as well as
started and founded companies from ground zero. His experience
includes leading three (3) companies to strategic exits (two (2)
private and one (1) public), raising over one hundred (100) million
dollars of public and private capital, managing numerous mergers
and acquisitions, leading companies through explosive growth as
well as rightsizing, and being recruited to turn around stalled
companies. He recently was the CEO and Co-founder of Trinity IT
Services LLC and CEO of TrekSecure LLC. A seasoned executive, his
experience also includes being Chairman and EVP of ShipXpress which
GE acquired, being CEO of Giga (NASDAQ GIGA) where he led the
company’s sale to Forrester Research (NASDAQ FORR) and being the
CEO of e-Medsoft which went public. His fortune 300 corporate
experience includes being CIO and SVP of CSX Transportation at CSX
(NASDAQ CSX) corporation managing thousands of employees. During
his tenure at CSX, he was credited in achieving over five hundred
(500) million dollars in operating expense reductions through his
visionary and portfolio technology projects. As CIO he received
several industry awards to include CIO of the year from Information
Week and top industry visionary from Computerworld. While at CSX,
Andrews also consulted with Sun Microsystems (NASDAQ SUNW) on the
development of JAVA. Prior to CSX Andrews held executive positions
with telecom giant GTE, to include division CIO, President
Government Information Systems and President Healthcare Information
Systems. Andrews has an MBA from the University of Puget-Sound,
Seattle WA, and a BA, Business Administration and Finance from
Whitworth University, Spokane WA.
Joel Kanter, Applied UV’s Chairman of the Board, stated, “We are
thrilled to have been able to attract John to Applied UV. While the
Company has completed a lot of ‘foundational building’ in the last
year with the multiple acquisitions and offerings, now it is time
to move to the ‘building phase’ when we hope to be better
disciplined in choosing our opportunities, and generate the
disciplined growth we hoped would result from the accumulation of
superb products. John’s vast experience in growing superb and
focused teams, that are then able to engender the growth we and our
shareholders believe is possible, is a huge step forward in
ultimately seeing these hopes become a reality. We look forward
with great excitement to what will be achieved in the coming months
and years.”
John Andrews states, “I am thrilled to have the opportunity of
leading Applied UV at this most important time for the company as
we are in position to accelerate our growth in the global air
purification and pathogen elimination market. The growing market
tailwinds created by the recent government initiatives, guidelines
and policies surrounding improving indoor air, Applied UV’s best in
class suite of air purification technologies is well suited to fill
this growing global demand of cleaner in-door air and pathogen
elimination. I look forward to working together with our Board of
Directors, senior executives, employees, and consultants as we
embark upon this journey.”
About Applied UV
Applied UV is focused on the development and acquisition of
technology that address infection control in the healthcare,
hospitality, commercial and municipal markets. The Company has two
wholly owned subsidiaries - SteriLumen, Inc. (“SteriLumen”) and
Munn Works, LLC (“Munn Works”). SteriLumen’s connected platform for
Data Driven Disinfection™ applies the power of ultraviolet light
(UVC) to destroy pathogens safely, thoroughly, and automatically,
addressing the challenge of healthcare-acquired infections
(“HAIs”). Targeted for use in facilities that have high customer
turnover such as hospitals, hotels, commercial facilities, and
other public spaces, the Company’s Lumicide™ platform uses UVC LEDs
in several patented designs for infection control in and around
high-traffic areas, including sinks and restrooms, killing
bacteria, viruses, and other pathogens residing on hard surfaces
within devices’ proximity. The Company’s patented in-drain
disinfection device, Lumicide Drain, is the only product on the
market that addresses this critical pathogen intensive location.
SteriLumen’s Airocide® air purification devices are research
backed, clinically proven and developed for NASA with assistance
from the University of Wisconsin. Airocide® is listed as an FDA
Class II Medical device, utilizes a proprietary photocatalytic
(PCO) bioconversion technology that draws air into a reaction
chamber that converts damaging molds, microorganisms, dangerous
airborne pathogens, destructive VOCs, allergens, odors and
biological gasses into harmless water vapor and green carbon
dioxide without producing ozone or other harmful byproducts.
Airocide® applications include healthcare, hospitality, grocery
chains, wine making facilities, commercial real estate, schools,
dental offices, post-harvest, grocery, cannabis facilities and
homes. For more information about Applied UV, Inc., and its
subsidiaries, please visit the following websites:
https://www.applieduvinc.com/; https://sterilumen.com/;
https://www.airocide.com https://kesscience.com;
https://scientificairmanagement.com and,
https://munnworks.com/.
Forward-Looking Statements
The information contained herein may contain “forward‐looking
statements.” Forward‐looking statements reflect the current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” or the negative of these terms and similar expressions, as
they relate to us or our management, identify forward‐looking
statements. Such statements include, but are not limited to,
statements contained in this press release relating to the view of
management of Applied UV concerning its business strategy, future
operating results and liquidity and capital resources outlook.
Forward‐looking statements are based on the Company’s current
expectations and assumptions regarding its business, the economy
and other future conditions. Because forward–looking statements
relate to the future, they are subject to inherent uncertainties,
risks and changes in circumstances that are difficult to predict.
The Company’s actual results may differ materially from those
contemplated by the forward‐looking statements. They are neither
statements of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward‐looking statements. Factors or events that could
cause the Company’s actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward‐looking
statements to conform these statements to actual results.
For additional Company Information: Applied UV
Inc. John F. Andrews Applied UV CEO, Director
john.andrews@applieduvinc.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220408005101/en/
Brett Maas, Managing Principal Hayden IR brett@haydenir.com
(646) 536-7331
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied UV (NASDAQ:AUVI)
Historical Stock Chart
From Sep 2023 to Sep 2024